Is Resveratrol Safe with NMN?
Free · No account · based on published sources including NIH ODS, FDA drug labels, and peer-reviewed literature
Cancer patients should consult their oncologist before combining NMN and resveratrol. This combination is not recommended during active cancer treatment due to theoretical concerns about cellular survival pathway activation.
Why this interaction occurs
NMN raises intracellular NAD+ levels, which are required for SIRT1 deacetylase activity. Resveratrol is commonly promoted as a SIRT1 activator. In cancer patients, enhanced NAD+/SIRT1 signaling may promote cancer cell survival, resistance to apoptosis, and DNA damage repair in tumor cells, potentially counteracting chemotherapy or radiation therapy effects. While evidence in humans remains limited, the mechanistic concern is clinically relevant.
Evidence
Evidence level: limited.
Reported safety data
The FDA’s adverse event reporting system (FAERS) has received 8 reports mentioning NMN. This reflects reported cases involving the medication in general — not confirmed causation, and not specific to the NMN + supplement combination on this page.
FAERS reports are voluntary and cannot prove that a drug caused an event. Do not use report counts to assess the safety of this specific drug-supplement pair.
Frequently asked questions
Related interactions
All Resveratrol interactions → · All NMN interactions →
Already checked this one — check your whole list
Educational only — not medical advice.
Always confirm with your doctor or pharmacist.